Chancroid in El Salvador. Increasing incidence, clinical features, and therapeutics.
O Orellana-Díaz, E Hernández-Pérez
Index: Int. J. Dermatol. 27(4) , 243-5, (1988)
Full Text: HTML
Abstract
Ninety-five cases of chancroid were studied during a 6-month period in a dermatologic service in San Salvador; 88 (92.6%) were men and 7 (7.4%) were women, with a ratio of 12.5:1. The minimum age was 13 years and the maximum 46, with an average of 21 years. In most of the cases (81.05%), the incubation period varied from 1 to 7 days. Very painful adenopathies, enough to make walking difficult, were a striking feature in 69 cases (72.6%). Treatment was curative in all cases, except two, who received treatment with co-trifamole (sulfatrifamole 400 mg/trimethoprim 80 mg). In two cases in which it was not possible to use co-moxole (allergy, pregnancy), treatment was also curative using erythromycin.
Related Compounds
Related Articles:
1996-03-01
[Adverse Drug React. Toxicol. Rev. 15(1) , 9-50, (1996)]
Combination of trimethoprim with sulfonamides other than sulfamethoxazole.
1982-01-01
[Rev. Infect. Dis. 4(2) , 411-8, (1982)]
Use of p-benzoquinone for the spectrophotometric determination of certain sulphonamides.
1991-01-01
[J. Pharm. Biomed. Anal. 9(7) , 531-8, (1991)]
1982-09-01
[Br. J. Clin. Pharmacol. 14(3) , 437-43, (1982)]
[Supristol suspension in pediatrics].
1980-12-01
[Lille Med. 25(10) , 611-2, (1980)]